Khalid El Bairi: From Oncology Research to Editorial Leadership at JCO Global Oncology
Khalid El Bairi: From Oncology Research to Editorial Leadership at JCO Global Oncology Oncodaily
1636 материалов по теме, собраны автоматически из проверенных источников
Khalid El Bairi: From Oncology Research to Editorial Leadership at JCO Global Oncology Oncodaily
USC scientists have discovered a way to create a potentially renewable supply of genetically engineered immune cells that can attack cancer and strengthen the body's natural defenses. By growing and modifying immature immune cells rather than mature ones, researchers developed a system that can continuously produce…
Новое исследование: белок, способствующий развитию рака, также может быть ключом к борьбе с ним Поиск - новости науки и техники
Indian-American cancer researcher Rachna Shroff dies following a long battle with 'aggressive cancer' The Times of India
Dana-Farber’s personalized cancer vaccine NeoVax shows immune activity in ovarian cancer trial AllSci
The question of whether a biosimilar is as comparably effective as its originator has largely been put to rest by clinical trials, real-world experience and a recent FDA guidance. However, this has not made biosimilars more accessible or affordable. “As with all things in the prescription drug space, there are a lot…
KHCF/KHCC Launches the Fourth Annual Cancer Research Conference 2026 Oncodaily
Michele Carbone and Laura Esserman Receive Honors for Impact on Cancer Research - NFCR Oncodaily
GLP-1 and Cancer: What Research Shows About Cancer Risk and Prevention Oncodaily
The Comparator Arm Is the Trial: Why OptiTROP-Lung05’s Design Debate Exposes a Structural Problem in Oncology Phase 3s The Clinical Trial Vanguard
Indian-American cancer researcher dies at 47 after battling the disease she spent her career fighting Gulf News
Исследования позволяют выявить способы повышения способности иммунных клеток бороться с раком. Vietnam.vn
Oncolytics Biotech Completes GOBLET Pancreatic Cancer Cohort Enrollment The Clinical Trial Vanguard
CORRECTION: Nuvation Bio's SIGMA Phase 3 Study for Grades 2, 3, and 4 Glioma Brain Cancer Akron Beacon Journal
Исследование ученых. Заболеваемость раком среди молодежи растет, несмотря на улучшение образа жизни NV Техно